The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.

Jeschke U, Walzel H, Mylonas I, Papadopoulos P, Shabani N, Kuhn C, Schulze S, Friese K, Karsten U, Anz D, Kupka MS. J Histochem Cytochem. 2009 Sep;57(9):871-81. doi: 10.1369/jhc.2009.952085.

Read more
Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.

Jeschke U, Mylonas I, Kunert-Keil C, Stahn R, Scholz C, Janni W, Kuhn C, Schröder E, Mayr D, Friese K. Histochem Cell Biol. 2009 Feb;131(2):283-95. doi: 10.1007/s00418-008-0510-z.

Read more
Novel Glycosylation Technologies for the Development of Biosimilars and Biobetters.

Baumeister H, Goletz S. In: Innovations In Pharmaceutical Technology 2009: Dec.

Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.

Dian D, Janni W, Kuhn C, Mayr D, Karsten U, Mylonas I, Friese K, Jeschke U. Onkologie. 2009 May;32(5):238-44. doi: 10.1159/000209280.

Read more
Modifying antibody specificity by chain shuffling of V / V between antibodies with related specificities.

Christensen PA, Danielczyk A, Ravn P, Larsen M, Stahn R, Karsten U, Goletz S. Scand J Immunol. 2009 Jan;69(1):1-10. doi: 10.1111/j.1365-3083.2008.02164.x.

Read more